Vanboeijen, Centre for the Intellectually Disabled, Assen, The Netherlands.
J Intellect Disabil Res. 2010 Jul;54(7):659-67. doi: 10.1111/j.1365-2788.2010.01275.x. Epub 2010 Apr 20.
We investigated antipsychotic drug prescription practice of Dutch ID physicians, studying prevalence of antipsychotic drug use, reasons for prescription and the relationship between these reasons and patient characteristics.
A cross-sectional study of medical and pharmaceutical records in a population living in residential settings of three care providers for persons with IDs in the Netherlands (n = 2373).
Prevalence of antipsychotic drug use was 32.2% (95% CI 30.1-33.9). Behavioural problems were the reason for prescription of antipsychotic drugs in 58% of cases and psychotic disorder or psychotic symptoms in 22.5%. In 11.7% the diagnosis of psychotic disorder was specified according to DSM-IV criteria. In 18.5% the reason for prescription was not noted in the medical record. Behavioural problems as reason for prescription was associated with profound and severe ID, living in a central location and male sex. Psychotic disorder specified according to DSM-IV as indication for prescription was negatively associated with profound and severe ID and with presence of an additional mental disorder. Absence of a noted reason for prescription was associated with female sex and with the presence of an additional mental disorder.
Current prevalence and reason for prescription of antipsychotic drugs are similar with outcomes of previous studies. Our results show the continuing lack of evidence-based psychopharmacological treatment in mental health care for persons with IDs.
我们研究了荷兰 ID 医生的抗精神病药物处方实践,研究了抗精神病药物的使用情况、处方的原因以及这些原因与患者特征之间的关系。
这是一项在荷兰三家 ID 患者居住机构的护理提供者中进行的横断面研究,对医疗和药物记录进行了调查(n = 2373)。
抗精神病药物使用率为 32.2%(95%CI 30.1-33.9)。行为问题是 58%的患者使用抗精神病药物的原因,而精神障碍或精神症状则占 22.5%。11.7%的患者按照 DSM-IV 标准明确诊断为精神障碍。18.5%的病历中未记录处方的原因。将行为问题作为处方的原因与严重的智力障碍、居住在中心位置和男性性别有关。根据 DSM-IV 规定将精神障碍明确为处方的指征与严重的智力障碍和存在其他精神障碍有关。未记录处方的原因与女性性别和存在其他精神障碍有关。
目前抗精神病药物的使用情况和使用原因与以往研究的结果相似。我们的研究结果表明,在 ID 患者的精神卫生保健中,仍然缺乏基于证据的精神药理学治疗。